Emzor Pharmaceutical reiterated its dedication to developing local drug production in Africa to enhance health resilience, speaking at the ECOWAS @50 summit in Lagos
[dropcap]E[/dropcap]mzor Pharmaceutical Industries Limited has reaffirmed its strong and ongoing commitment to the development and growth of the local pharmaceutical sector across Africa, aiming to significantly strengthen health resilience throughout the continent.
Also read: ECOWAS Court of Justice visits Lagos as Chief Judge Alogba reacts to regional breakaway
Speaking at the ECOWAS @50 sub-regional summit held in Lagos, Uzoma Ezeoke, Executive Director of Emzor, emphasized the firm’s strategic prioritization of Africa as a key market.
Emzor pledged to continue scaling up the development and local production of high-quality drugs and essential medical supplies that meet international standards.
This initiative is crucial to bridging the existing gap in healthcare access across the continent.
The two-day summit, organized by the Lagos Chamber of Commerce and Industry (LCCI), centered on the theme, “Regional Integration: Gateway to Peace and Security, Trade and Investment in the ECOWAS Sub-Region, Achievements, Challenges, Solutions and Opportunities.”
In her presentation titled “Local Manufacturing Equals Medicine Security,” Ezeoke highlighted Emzor’s strategic interventions aimed at ensuring medicine self-sufficiency and building capacity within Africa.
These efforts include the local manufacture of over 160 pharmaceutical products across five factory sites, supported by a workforce exceeding 2,000 employees.
Ezeoke noted that Emzor’s plants in Sagamu are designed to world-class standards, and its high-quality products are distributed to between 23 and 27 African countries, with direct exports to Liberia and Sierra Leone.
She underscored the significance of Emzor’s groundbreaking Active Pharmaceutical Ingredients (API) plant in Sagamu, Ogun State, as a testament to the company’s innovation and forward-thinking approach to addressing Africa’s drug sufficiency challenges.
This is particularly critical in stemming the high rates of maternal and infant mortality linked to malaria. The API facility will significantly increase the production of high-quality antimalarials and other WHO-recommended priority drugs.
Ezeoke stated that the establishment of the API plant will substantially reduce the continent’s reliance on drug imports, a major pathway for substandard, falsified, and fake medications entering Africa.
“At Emzor, we are preparing for the future of Africa, including deepening our pathways in the English and French-speaking West African countries,” said Uzoma Ezeoke, Executive Director of Emzor Pharmaceuticals.
The plant is also expected to reduce foreign exchange dependency, boost local production capacity, improve access to quality healthcare for a larger population, and contribute to Gross Domestic Product growth across the continent.
She emphasized Emzor’s focus on product innovation and quality, strategically addressing identified market failures and gaps within the healthcare system, particularly in research, development, and local production of high-quality drugs for maternal and child health challenges.
Examples of Emzor’s innovations include dispersible tablets for children, the development of Ready-to-Use Therapeutic Food (RUTF) for malnutrition through a USAID-backed backward integration project with local farmers, and solutions for postpartum bleeding.
Despite the stringent regulatory environments in both English and French-speaking West African countries, Ezeoke affirmed Emzor’s commitment to playing a pivotal frontier role in strengthening the sub-region’s health resilience.
She also highlighted the importance of understanding diverse cultural perspectives for businesses operating in multinational African contexts.
Ezeoke acknowledged the Federal Government’s dedication to elevating manufacturing quality and the regulatory framework, noting that Nigeria has the largest number of pharmaceutical manufacturers on the continent.
Also read: Mobihealth, Medicaid Cancer Foundation, WorldCare partner to revolutionize affordable cancer care in Africa
Other speakers at the summit, including the President of the LCCI, Mr. Gabriel Idahosa, and representatives from the ECOWAS Bank for Investment and Development (EBID), also emphasized the importance of regional integration for economic progress, peace, and security within the ECOWAS sub-region.
